Stents have revolutionized the treatment of obstructive coronary disease by improving the safety of percutaneous coronary intervention (PCI) and reducing the need for repeat revascularization. First-generation drug-eluting stents (DES) were highly efficacious, as they further reduced the need for reintervention, but they left room for improvement in safety and stent deliverability. Newer-generation DES were designed for better biocompatibility and deliverability. Nevertheless, only few clinical data on the safety and efficacy of these newer-generation DES are available. This thesis has investigated various aspects of both safety and efficacy of newer-generation DES.
|Award date||25 Jun 2014|
|Place of Publication||Enschede|
|Publication status||Published - 25 Jun 2014|